Taxol treatment of cancer

USRE40839E1 · kind E1 · reissue

Assignee

• The United States of America, as represented by the Department of Health and Human Services · US

Inventors

• Wyndham Wilson · Washington, US
• Robert E. Wittes · Washington, US
• Antonio Fojo · Rockville, US
• Susan E. Bates · Bethesda, US

Key dates

• Filing date: Mar 5, 1998
• Grant date: Jul 7, 2009
• Expiry date: Mar 5, 2018

Classification

• Technology area (CPC —): General

Abstract

The present invention is a method of treatment for a patient with cancer. In particular, it is a method of treating patients having lymphomas and breast cancer using the microtubule agent, Taxol. The present method of administration, serves to prevent or retard the adverse side effects associated with Taxol and reduces the chances of a patient developing mdr Taxol resistance. The novel method of treatment provides a low-dose, long-term exposure to Taxol in a patient.